| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 11/02/2004 | CA2112014C Antiallergic composition for ophthalmic or nasal use |
| 10/28/2004 | WO2004092179A1 Spiro derivative, production process, and antioxidant |
| 10/28/2004 | WO2004092169A1 Spiropiperidine compound and medicinal use thereof |
| 10/28/2004 | WO2004092163A1 Phenylazole compound, production process, and antioxidant drug |
| 10/28/2004 | WO2004092153A1 Diamine derivative, production process, and antioxidizing drug |
| 10/28/2004 | WO2004091662A1 Agent for repairing corneal perception |
| 10/28/2004 | WO2004091659A1 Drug for preventing or treating angiogenic eye diseases |
| 10/28/2004 | WO2004091630A1 Remedies for diseases to be applied to eye |
| 10/28/2004 | WO2004091605A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 10/28/2004 | WO2004091438A2 Improved ophthalmic and contact lens solutions containing peptides as representative enhancers |
| 10/28/2004 | WO2004076626A3 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor |
| 10/28/2004 | WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/28/2004 | WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 10/28/2004 | WO2003030833A3 Angiopoietin-2 specific binding agents |
| 10/28/2004 | US20040214886 for the treatment and/or prophylaxis of diseases, in particular, states of pain and neurodegenerative disorders |
| 10/28/2004 | US20040214875 Imidazolinylmethyl aralkylsulfonamides |
| 10/28/2004 | US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens |
| 10/28/2004 | US20040214822 Substituted 4-aminocyclohexanol compounds |
| 10/28/2004 | US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | CA2527175A1 Remedies for diseases to be applied to eye |
| 10/28/2004 | CA2522266A1 Phenylazole compound, production process therefor and antioxidant |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 10/27/2004 | EP1470818A1 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns |
| 10/27/2004 | EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470256A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE /GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 10/27/2004 | EP1470246A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 10/27/2004 | EP1470150A2 Corticosteroids nitrate derivatives |
| 10/27/2004 | EP1470148A2 Double-stranded oligonucleotides |
| 10/27/2004 | EP1470138A1 Mmp inhibitors |
| 10/27/2004 | EP1470137A1 Edg receptor agonists |
| 10/27/2004 | EP1470122A1 Rho-kinase inhibitors |
| 10/27/2004 | EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 10/27/2004 | EP1470112A1 Substituted pyridazinones as inhibitors of p38 |
| 10/27/2004 | EP1470107A2 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
| 10/27/2004 | EP1469887A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 10/27/2004 | EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 10/27/2004 | EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 10/27/2004 | EP1469841A1 Alpha 2 delta ligands to treat tinnitus |
| 10/27/2004 | EP1469828A2 Ophthalmic compositions including oil-in-water emulsions, and methods for making and using the same |
| 10/27/2004 | EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP0918795B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 10/27/2004 | CN1541275A Glycoprotein and process for producing same |
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1541208A 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/27/2004 | CN1539454A Preparaton of banlangen and method for controlling quality |
| 10/27/2004 | CN1539429A Deoxyadenosine in aplication of preparing bypolipidemic |
| 10/27/2004 | CN1539422A Liquid preparation made from pazufloxacin leucinocaine fed through eye in application of curing ophthalmic diseases and producing method |
| 10/27/2004 | CN1172719C Preventives/remedies/progression inhibitors for simplex retinopathy or preproliferating retinopathy |
| 10/27/2004 | CN1172711C Chinese medicine preparation for curing chronic conjunctivitis |
| 10/27/2004 | CN1172688C External medicine for treating tympanitis |
| 10/27/2004 | CN1172673C Use of staurosporine derivatives for treating ocular neovascular diseases |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809119 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
| 10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
| 10/26/2004 | US6808719 Interior core in well containing active materials; aperture to exterior |
| 10/26/2004 | CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/21/2004 | WO2004089988A2 Inhibitors of integrin alpha5beta1 and their use for the control of tissue granulation |
| 10/21/2004 | WO2004089399A1 Novel uses of rfrp and ot7t022 |
| 10/21/2004 | US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 10/21/2004 | US20040209957 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke |
| 10/21/2004 | US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 10/21/2004 | US20040209901 substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors. |
| 10/21/2004 | US20040209894 e.g., 1-(4-chloroanilino)-4-[2-(pyridin-3-yl)-ethyl]-isoquinoline and 5-[4-(tert-butyl)-anilino]-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine |
| 10/21/2004 | US20040209888 Methods of treating dry eye disorders |
| 10/21/2004 | US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 10/21/2004 | US20040209832 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| 10/21/2004 | US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability |
| 10/21/2004 | US20040208909 comprising a drug core, a unitary cup, and a permeable plug; for delivering multiple agents directly to the interior portions of the body of a mammalian organism, such as to eye |
| 10/21/2004 | CA2520121A1 Inhibitors of integrin alpha5beta1 and their use for the control of tissue granulation |
| 10/20/2004 | EP1469077A1 Cell-specific expression/replication vector |
| 10/20/2004 | EP1468695A1 Methods and compositions useful for inhibition of angiogenesis |
| 10/20/2004 | EP1468686A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders |
| 10/20/2004 | EP1468684A1 Sigma receptor binder containing indanone derivative |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/20/2004 | EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof |
| 10/20/2004 | EP1467761A1 Treatment of neovascular ophthalmic disease |
| 10/20/2004 | EP1467760A2 Systems and methods for photodynamic therapy |
| 10/20/2004 | EP1467734A1 Cotherapy with an oxazolidinone and a vitamin b |
| 10/20/2004 | EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 10/20/2004 | EP1467728A1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 10/20/2004 | EP1467722A2 Use of an anti-microtubule agent for the treatment of uveitis |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1404180A4 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 10/20/2004 | EP1151008B1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 10/20/2004 | EP1131291B1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 10/20/2004 | CN1539010A Fermentation product of cryptoporus volvatus and its preparation method and application |
| 10/20/2004 | CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease |